Analog Devices Inc: Form 10-Q for the period ended Jul 31, 2021
Filed with the SEC on Aug 18, 2021 and accepted by EDGAR at Aug 18, 2021, 07:06 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-05-02 to 2021-07-31 | $1.76bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2020-11-01 to 2021-07-31 | $4.98bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-05-02 to 2021-07-31 | $537.7m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2020-11-01 to 2021-07-31 | $1.58bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months2021-05-02 to 2021-07-31 | $1.22bn | us-gaap:GrossProfit |
| Gross profit | 9 months2020-11-01 to 2021-07-31 | $3.40bn | us-gaap:GrossProfit |
| Research and development | 3 months2021-05-02 to 2021-07-31 | $306.6m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2020-11-01 to 2021-07-31 | $897.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2021-05-02 to 2021-07-31 | $206.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2020-11-01 to 2021-07-31 | $598.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2021-05-02 to 2021-07-31 | $609.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-11-01 to 2021-07-31 | $1.59bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-05-02 to 2021-07-31 | $44.7m | us-gaap:InterestExpense |
| Interest expense | 9 months2020-11-01 to 2021-07-31 | $130.2m | us-gaap:InterestExpense |
| Income tax | 3 months2021-05-02 to 2021-07-31 | $69.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-11-01 to 2021-07-31 | $170.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-05-02 to 2021-07-31 | $503.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-11-01 to 2021-07-31 | $1.31bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-05-02 to 2021-07-31 | $1.35 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2020-11-01 to 2021-07-31 | $3.53 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-05-02 to 2021-07-31 | $1.37 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2020-11-01 to 2021-07-31 | $3.56 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-05-02 to 2021-07-31 | 371,849,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2020-11-01 to 2021-07-31 | 372,457,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2020-11-01 to 2021-07-31 | $1.79bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2020-11-01 to 2021-07-31 | $212.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2020-11-01 to 2021-07-31 | $738.1m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2020-11-01 to 2021-07-31 | $509.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-07-31 | $1.48bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-07-31 | $3.09bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-07-31 | $21.64bn | us-gaap:Assets |
| Current liabilities | At period end2021-07-31 | $2.79bn | us-gaap:LiabilitiesCurrent |
| Current portion of debt | At period end2021-07-31 | $1.32bn | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2021-07-31 | $12.26bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2021-07-31 | 368,214,341 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000006281-21-000197. Last ingested by Listed: Oct 27, 2026, 17:29 ET. Listed shows no prices and gives no investment advice.